
bit.bio
bit.bio is an award-winning human synthetic biology company whose mission is to code cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox™ precision cell programing technology, bit.bio can deterministically program human induced pluripotent stem cells (iPSCs) into a chosen cell identity with unprecedented biological consistency at an industrial scale and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.
Latest bit.bio Content

Functional, Reprogrammed Microglia To Study Neurodegeneration

Driving Genome-Wide Consistency in Cellular Reprogramming

bit.bio Launches New Custom Disease Model Cells Offering

ioSensory Neurons: Human iPSC-Derived Neurons for Reliable Pain Research

Precision Cellular Reprogramming for Scalable and Consistent Human Neurodegenerative Disease Models

Four Hacks for Culturing Neurons

Modeling Neurodegeneration Using a Human Isogenic System

Modeling Neurodegeneration: A Next-Generation Approach To Study Huntington’s Disease

Rethinking Developmental Biology With Cellular Reprogramming
